Upload
sarfarazpk1
View
226
Download
2
Embed Size (px)
DESCRIPTION
DMF Open part
Citation preview
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
THETHETHETHE COMMONCOMMONCOMMONCOMMON TECHNICALTECHNICALTECHNICALTECHNICAL DOCUMENTDOCUMENTDOCUMENTDOCUMENT 3.2.S3.2.S3.2.S3.2.S FORFORFORFOR THETHETHETHEREGISTRATIONREGISTRATIONREGISTRATIONREGISTRATION OFOFOFOF PHARMACEUTICALSPHARMACEUTICALSPHARMACEUTICALSPHARMACEUTICALS FORFORFORFOR HUMANHUMANHUMANHUMAN USE:USE:USE:USE:
SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
OpenOpenOpenOpen partpartpartpart
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTD.LTD.LTD.LTD.GeneralGeneralGeneralGeneral Pharma.Pharma.Pharma.Pharma. FactoryFactoryFactoryFactory
2020202011111111
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.13.13.13.1 TABLETABLETABLETABLE OFOFOFOF CONTENTSCONTENTSCONTENTSCONTENTS OFOFOFOF MODULEMODULEMODULEMODULE 33333.23.23.23.2 BODYBODYBODYBODY OFOFOFOF DATADATADATADATA3.2.S DRUG SUBSTANCE3.2.S.1 General Information3.2.S.1.1 Nomenclature3.2.S.1.2 Structure3.2.S.1.3 General Properties3.2.S.2 Manufacture3.2.S.2.1 Manufacturer(s)3.2.S.2.2 Description of Manufacturing Process and Process Controls3.2.S.2.3 Control of Materials3.2.S.2.4 Control of Critical Steps and Intermediates3.2.S.2.5 Process Validation and/or Evaluation3.2.S.2.6 Manufacturing Process Development3.2.S.3 Characterization3.2.S.3.1 Elucidation of Structure and other Characteristics3.2.S.3.2 Impurities3.2.S.4 Control of Drug Substance3.2.S.4.1 Specification3.2.S.4.2 Analytical Procedures3.2.S.4.3 Validation of Analytical Procedures3.2.S.4.4 Batch Analyses3.2.S.4.5 Justification of Specification3.2.S.5 Reference Standards or Materials3.2.S.6 Container Closure System3.2.S.7 Stability3.2.S.7.1 Stability Summary and Conclusions3.2.S.7.2 Post-approval Stability Protocol and Stability Commitment3.2.S.7.3 Stability Data
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.23.23.23.2 BODYBODYBODYBODY OFOFOFOF DATADATADATADATA3.2.S3.2.S3.2.S3.2.S DRUGDRUGDRUGDRUG SUBSTANCESUBSTANCESUBSTANCESUBSTANCE3.2.S.13.2.S.13.2.S.13.2.S.1 GeneralGeneralGeneralGeneral InformationInformationInformationInformation
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.1.13.2.S.1.13.2.S.1.13.2.S.1.1 NomenclatureNomenclatureNomenclatureNomenclature
GeneralGeneralGeneralGeneral remarkremarkremarkremarkThis Drug Master File has been compiled to provide the necessary information for the evaluationof suitability of the bulk substance of CEFOPERAZONE SODIUMmanufactured by HarbinPharmaceutical Group CoLtd
It is used as active substance for medicinal products(dosage forms)which are blended withsulbactam sodium generally. The structure of the document represents the section 3.2.S of themodule 3 of the Common Technical Document(CTD)Thusit is appropriate to be integrated in thequality part of an application for marketing authorization
The content of this Active Substance Master File is property of Harbin Pharmaceutical Group CoLtd. and thereforeit is confidentialThis document should not be disclosed no matter if in wholeor in part Not any parties other than customers and government employees required forregulatory purposes are authorized to have access to its content
The manufacture of cefoperazone sodium is performed according to the presented dossier and totheGood Manufacturing Practice of the Peoples Republic of China.
On request of relevant authorities and customers the inspection regarding the manufacture ofcefoperazone sodium is possible
Cefoperazone sodium is an antibiotic compound of the third generation of cephaIosporins Itshows a high resistance against -lactamase And because sulbactam can strengthen theantibacterial activity of it, cefoperazone sodium has been often blended with sulbactam sodium tocomply the requirements of customers.
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
The active ingredient is commonly known under the name
CefoCefoCefoCefoperazoneperazoneperazoneperazone sodiumsodiumsodiumsodium
This term is used in the compendial title of the monograph of the European Pharmacopoeiapublished in its current editionThe cefoperazone sodium produced by Harbin PharmaceuticalGroup CoLtdNangang DistrictChina corresponds to the quality standard of this monograph
ChemicaIChemicaIChemicaIChemicaI namesnamesnamesnames
SodiumSodium(6R,7R)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.(EP 6.0)
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl
-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6 ,7 (R*)]]-.
(USP 32)
Sodium(6R,7R)-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido-3-[[(1-methyl-H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(USP 32)
CAS-Registry-NumberCAS-Registry-NumberCAS-Registry-NumberCAS-Registry-Number
[62893-20-3]
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.1.23.2.S.1.23.2.S.1.23.2.S.1.2 StructureStructureStructureStructure
The chemical structure of cefoperazone sodium is exhibited below.
CefoCefoCefoCefoperazoneperazoneperazoneperazone sodiumsodiumsodiumsodium
MolecularMolecularMolecularMolecular formulaformulaformulaformula
C25H26N9NaO8S2
RelativeRelativeRelativeRelative molecularmolecularmolecularmolecular massmassmassmass
668
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.1.33.2.S.1.33.2.S.1.33.2.S.1.3 GeneralGeneralGeneralGeneral PropertiesPropertiesPropertiesProperties
AppearanceAppearanceAppearanceAppearanceA white or slightly yellow powder
HygroscopicityHygroscopicityHygroscopicityHygroscopicityHygroscopic
pkpkpkpkaaaa-value-value-value-valueThe pH of the solution is 4.5 to 6.5.
InfraredInfraredInfraredInfrared absorptionabsorptionabsorptionabsorption spectrophotometryspectrophotometryspectrophotometryspectrophotometryExamine by infrared absorption spectrophotometry (2.2.24), comparing with the Ph. Eur. referencespectrum of cefoperazone sodium.
SolubilitySolubilitySolubilitySolubilityFreely soluble, in water, soluble in methanol, slightly soluble in alcohol.
PolymorphismPolymorphismPolymorphismPolymorphismIf crystalline, it shows polymorphism.
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.23.2.S.23.2.S.23.2.S.2 ManufactureManufactureManufactureManufacture
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.13.2.S.2.13.2.S.2.13.2.S.2.1 Manufacturer(s)Manufacturer(s)Manufacturer(s)Manufacturer(s)
The name and address of the manufacturing site of the active ingredient manufacturer is:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTD.LTD.LTD.LTD. GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
No. 109 Xuefu RoadNangang Dist.Harbin, Peoples Republic of China
Tel: 0086-0451-86665134Fax: 0086-0451-86662959E-mail: [email protected]
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.23.2.S.2.23.2.S.2.23.2.S.2.2 DescriptionDescriptionDescriptionDescription ofofofof ManufacturingManufacturingManufacturingManufacturing ProcessProcessProcessProcess andandandand ProcessProcessProcessProcess ControlsControlsControlsControls
A.A.A.A. SyntheticSyntheticSyntheticSynthetic routerouterouteroute
CefoperazoneCefoperazoneCefoperazoneCefoperazone acidacidacidacid
PreparationPreparationPreparationPreparation ofofofof TZATZATZATZA
DissolveDissolveDissolveDissolve ofofofof TZATZATZATZA
NN
NS
N
CH3S
NH2N
OCOOSi(CH3)3
CH2CH3CN
BSACH2
COOHO
H2NN
S CH3
NNS
NN
AcylAcylAcylAcyl chloridechloridechloridechloride reactionreactionreactionreaction
AcylationAcylationAcylationAcylation
COCl
OH
CHNHCO
C2H5
O O
N N
CH2COOSi(CH3)3
O
H2NN
S CH3
NNS
NN
+
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
CH3C
OC NH CH
OH
O O
NC2H5 N
COOSi(CH3)3
HHO
NN
NSCH2
S
O NN
N
hydrolysishydrolysishydrolysishydrolysis
NC2H5 N
OO
OH
CHNHCO
CCH3
NN
NO
S
CH2 SN
NN
O HH
COOSi(CH3)3
H2O
HHO
NN
NSCH2
S
O NN
N
CH3C
OC NH CH
OH
O O
NC2H5 N
COOH
CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.33.2.S.2.33.2.S.2.33.2.S.2.3 ControlControlControlControl ofofofof MaterialsMaterialsMaterialsMaterials
In the following starting materials will be presented which are mentioned in the description of themanufacturing process in section 3.2.S.2.2:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
AAAAcetonitrilecetonitrilecetonitrilecetonitrile
MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: CH3CNMolecularMolecularMolecularMolecular weightweightweightweight:::: 41.05
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
BFBFBFBF3333-Acetonitrile-Acetonitrile-Acetonitrile-Acetonitrile
MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C 2H3NBF 3MolecularMolecularMolecularMolecular weightweightweightweight:::: 109Structure:Structure:Structure:Structure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole
MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C2H4N4SMolecularMolecularMolecularMolecular weightweightweightweight:::: 116.14Structure:Structure:Structure:Structure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
7-ACA7-ACA7-ACA7-ACA
MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C 10H 12N 2O 5SMolecularMolecularMolecularMolecular weightweightweightweight:::: 272.27Structure:Structure:Structure:Structure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
AmmoniaAmmoniaAmmoniaAmmonia WaterWaterWaterWater (refined)(refined)(refined)(refined)
MolecularMolecularMolecularMolecular formula:formula:formula:formula: NH4OH or NH3 H2OMolecularMolecularMolecularMolecular weight:weight:weight:weight: 35.10
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
AcetoneAcetoneAcetoneAcetone
MolecularMolecularMolecularMolecular formulaformulaformulaformula: C3H6OMolecularMolecularMolecularMolecular weightweightweightweight: 58.08StructureStructureStructureStructure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
6%6%6%6% sulfuroussulfuroussulfuroussulfurous acidacidacidacid
MolecularMolecularMolecularMolecular formulaformulaformulaformula: H2SO3MolecularMolecularMolecularMolecular weightweightweightweight: 82.08
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
N,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamide (BSA)(BSA)(BSA)(BSA)
MolecularMolecularMolecularMolecular formulaformulaformulaformula: C8H21NOSi2MolecularMolecularMolecularMolecular weightweightweightweight: 203.43StructureStructureStructureStructure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
DimethylacetamideDimethylacetamideDimethylacetamideDimethylacetamide ((((DMAC)DMAC)DMAC)DMAC)
MolecularMolecularMolecularMolecular formulaformulaformulaformula: CH3CON(CH3)2MolecularMolecularMolecularMolecular weightweightweightweight: 87.12StructureStructureStructureStructure:
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
PPPPhosphorushosphorushosphorushosphorus oxychlorideoxychlorideoxychlorideoxychloride
MolecularMolecularMolecularMolecular formulaformulaformulaformula: POCl3MolecularMolecularMolecularMolecular weightweightweightweight: 153.33
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
ActiveActiveActiveActive carboncarboncarboncarbon #767#767#767#767
MolecularMolecularMolecularMolecular formula:formula:formula:formula: CMolecularMolecularMolecularMolecular weight:weight:weight:weight: 12.01
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
SodiumSodiumSodiumSodium BicarbonateBicarbonateBicarbonateBicarbonate
MolecularMolecularMolecularMolecular formula:formula:formula:formula: NaHCO3MolecularMolecularMolecularMolecular weight:weight:weight:weight: 84.01
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.43.2.S.2.43.2.S.2.43.2.S.2.4 ControlsControlsControlsControls ofofofof CriticalCriticalCriticalCritical StepsStepsStepsSteps andandandand IntermediatesIntermediatesIntermediatesIntermediates
With reference to section 3.2.S.2.2 it is obvious from the description of the manufacturingprocess that during this process cefoperazone acid, as an isolated intermediate, isobtained. This cefoerazone acid is still nonsterile. For this reason a separateinprocess control of the key intermediate cefoperazone acid takes place and theanalytical tests are described. The reasonable inprocess specification ensures that thefinished active substance meets the specification.
PreparationPreparationPreparationPreparation ofofofof TZATZATZATZA
ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment
Condensationreaction
Temperature 121 Control thetemperature
Assay of 7-ACAafter reaction.
< 2.0 mg/ml
CrystallizationpH 3.1 ~ 3.3
Control usingammonia water
Temperature 91 Control thetemperature
CefoperazoneCefoperazoneCefoperazoneCefoperazone acidacidacidacid
ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment
Dissolve of TZA Temperature 20 ~23 Control using hot
waterAcyl chloridereaction
Temperature -25 ~ -30 Control using liquid
nitrogen
AcylationTemperature -302
Control using liquidnitrogen
Assay of TZA afteracylation.
< 2 %
Crystallization
Assay ofCefoperazone
side-chain acid < 3mg/ml after
crystallization.
< 3.0 mg/ml
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment
Forming sodiumsalt reaction
Temperature
pH
20 ~ 25
6.0 ~ 7.0
Control the temperatureusing ethylene glycol inmezzanine.Adjust using NaHCO3slowly.
Crystallization Temperature
How long the acetone dropping
26 2
For 4.5 hours
Control the temperatureusing ethylene glycol inmezzanine.
Centrifugalizationand washing
Turns when transfer crystallizationsolutionTurns when add washing solutionTurns when centrifugalization
600 50 rpm
600 50 rpm900 300 rpm
Adjust the turns permins.
Drying TemperatureWater
60 2 Hot water circulationEvacuate during drying
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.53.2.S.2.53.2.S.2.53.2.S.2.5 ProcessProcessProcessProcess ValidationValidationValidationValidation and/orand/orand/orand/or EvaluationEvaluationEvaluationEvaluation
Documentation on process validation is given in the Restricted Part of the ActiveSubstance Master File and is submitted directly to registration authorities on request.
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.2.63.2.S.2.63.2.S.2.63.2.S.2.6 ManufacturingManufacturingManufacturingManufacturing ProcessProcessProcessProcess DevelopmentDevelopmentDevelopmentDevelopment
Not applicable.
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.33.2.S.33.2.S.33.2.S.3 CharacterizationCharacterizationCharacterizationCharacterization
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.2.S.3.13.2.S.3.13.2.S.3.13.2.S.3.1 ElucidationElucidationElucidationElucidation ofofofof StructureStructureStructureStructure andandandand otherotherotherother CharacteristicsCharacteristicsCharacteristicsCharacteristicsChemicalChemicalChemicalChemical structurestructurestructurestructure analysisanalysisanalysisanalysis ofofofof CefoperazoneCefoperazoneCefoperazoneCefoperazone sodiumsodiumsodiumsodium
I.I.I.I. NameNameNameName ofofofof compoundcompoundcompoundcompound
Drug name (English): Cefoperazone Sodium
Chemical name (English):
Sodium
(6R,7R)-3-[[(1-methyl-H-tetrazol-5-yl)thio]methyl]-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxa
mido)-2-(phydroxy phenyl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylate
II.II.II.II. MolecularMolecularMolecularMolecular formulaformulaformulaformula andandandand molecularmolecularmolecularmolecular weightweightweightweight andandandand chemicalchemicalchemicalchemical structurestructurestructurestructure formulaformulaformulaformula
Molecular formula: C25H26N9NaO8S2
Molecular weight: 667.66
Structure formula:
III.III.III.III. UltraviletUltraviletUltraviletUltravilet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum
Apparatus:Cary 1E violet-visible spectrophotometer,America
Conditions:With 10g/ml and 12g/ml of test solution concentration respectively and 190-600nm
of scanning width.
1.1.1.1. UltravioletUltravioletUltravioletUltraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum
a.Ultraviolet absorption spectrum of RS
b.Ultraviolet absorption spectrum of test sample
2.Ultraviolet2.Ultraviolet2.Ultraviolet2.Ultraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum datadatadatadata ofofofof referencereferencereferencereference standardstandardstandardstandard
For methanol solution,1=200, 2=229,3=269
3.3.3.3. UltravioletUltravioletUltravioletUltraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum datadatadatadata ofofofof testtesttesttest samplesamplesamplesample
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
For methanol solution,1=200, 2=229,3=269
4.Conclusion:4.Conclusion:4.Conclusion:4.Conclusion: There exists -* and n-* band absorption in UV,which shows that the
compound contains the structure replacing the phenyl and carbonyl.
IV.ElementsIV.ElementsIV.ElementsIV.Elements analysisanalysisanalysisanalysis
Apparatus model:EA 1112E element analyzer,Flash company,Italia.
Test condition:Left oven temperature of reactor:950 C;Right oven temperature of reactor:
22C;Gas:High purity He and O2;Chromatographic column temperature: 75C.
Test data list of test sample:
Theoretical value Test value
Test I Test II Test III
C%H%N%S%
44.973.9318.889.61
43.374.2718.769.23
43.414.3318.729.41
43.394.3018.749.32
V.V.V.V. InfraredInfraredInfraredInfrared absorptionabsorptionabsorptionabsorption spectrum(IR)spectrum(IR)spectrum(IR)spectrum(IR)
Apparatus model:FTS-135 Fourier transform infrared spectrometer,BIO-RAD company,America.
Test condition:Adopt KBr pellet method
1.Infrared1.Infrared1.Infrared1.Infrared spectrogramspectrogramspectrogramspectrogram
a. Infrared spectrogram of RS
b.Infrared spectrum of test sample
2.2.2.2. InfraredInfraredInfraredInfrared spectrumspectrumspectrumspectrum testtesttesttest datadatadatadata tabletabletabletable ofofofof testtesttesttest samplesamplesamplesample
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
Note:strength: vs: extremely strong,s:strong,m:medium,w:weak
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
3.3.3.3. IRIRIRIR SpectrumSpectrumSpectrumSpectrum analysisanalysisanalysisanalysis
a.Wide and strong absorption centered at ~3400cm-1 is originated from OH stretching
vibration;Strong absorption entrapped in low wave number side of 1610 cm-1 and 1514cm-1 is
originated from benzene ring vibration(Vring);The OH changing angular vibration at 1365cm-1 and
C-O stretching vibration at 1174cm-1 is originated from phenol;The absorption at 841cm-1 is
originated from outside changing angular viabration of C-H side.All these data show that there
exists structure in the molecule.
b.Wide and strong absorption at 3287 cm-1 is originated from NH stretching
vibration(vNH);1680cm-1 is originated from amid I band;Absorption entrapped in 1514cm-1 is
originated from absorption on amid II band;Amid III band is at 1282cm-1 ;806cm-1 and 753cm-1 is
originated separately from amid V band and IV band;576cm-1 is originated from amid VI
band.Appearance of all these bands is connective with the amid structure .
c.Stretching virbration with high wave number C=O(vC=O) appearing at 1762 cm-1 is
characterization of structure.
d.1716cm-1 and 1670cm-1 (entrapped in the low wave number side of 1610 cm-1)is separatedly
originated from stretching vibration of two carbonyls in structure ,together considering
that characteristic vibration of CH2-CH2- appears at 753cm-1 and CH stretching vibration
(vas CH2)of CH2 at 2940cm-1 and changing angular vibration of CH2 at 1463cm-1 ,all these prove
that there exists structure in the molecule.
e.Addtionally,absorption band at 1610cm-1 involves N=N stretching vibration,while
1514cm-1 ,1365cm-1 ,1282cm-1 and 1109cm-1 is originated from stretching vibration of
ring,showing that there exists this structure in the molecule.697cm-1 and 618cm-1
can be classified as C-S stretching vibration,which is consistent with CH2-S- and
structure .
f.Absorption about at 1540cm-1 entrapped in the high frequency side of 1514cm-1 js
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
antisymmetry stretching vibration of carboxylic radical COO-(vas COO-).Together with the
symmetry stretching vibration(vas COO-)at 1392cm-1 ,all these prove there exists carboxylic
radical conjugating with C=C in the molecule.
g.IR spectrum of the test sample is consistent with that of the reference standard.
VI.VI.VI.VI.1111HHHH NMRNMRNMRNMR
Apparatus: Unity-400 nuclear magnetic resonance spectrometer,Varian,America.
Solvent:Deuterated dimethyl sulfoxide DMSO-d6 , standard reference
displacement:TMS=0.00;heavy water(D2O),reference displacementD20=4.7
i.i.i.i. One-dimensionalOne-dimensionalOne-dimensionalOne-dimensional 1111HHHH NMRNMRNMRNMR testtesttesttest
1. One-dimensional 1H NMR test
a. 1H NMR spectrum of reference standard
b. Heavy water exchange 1H NMR spectrogram of reference standard
c. 1H NMR spectrum of test sample
d. Heavy water exchange 1H NMR spectrogram of test sample
2. 1H NMR test data table of test sampleSerial no. ofpeak
Chemical shift
Multiplicity Couplingconstant(Hz)
Protonnumber
Correspondingproton
12345678910111213
9.939.729.307.206.745.565.514.874.414.213.913.71-3.321.08
bsddddddddddsmt
6.88.07.88.06.8,4.47.24.412.012.0
7.2
1112211111383
-OH>NH>CH=CH-=CH->CH->CH->CH--CH2--CH2--CH3-CH2--CH3
ii.ii.ii.ii. Two-dimensionalTwo-dimensionalTwo-dimensionalTwo-dimensional 1111H-H-H-H-1111HHHH correlatedcorrelatedcorrelatedcorrelated NMRNMRNMRNMR test(test(test(test(1111H-H-H-H-1111HHHH COSY)COSY)COSY)COSY)
1.Two-dimensional 1H-1H correlated NMR spectrogram of reference standard
2. Two-dimensional 1H-1H correlated NMR spectrogram of test sample
3. Two-dimensional 1H-1H correlated NMR test data table of test sample
Serial no. Chemical shift Correlated peak shift
Crossing peak intensity
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
12345678910
9.729.307.206.745.565.514.414.213.371.08
5.515.566.747.209.309.724.214.411.083.37
mwsswmssss
iii.iii.iii.iii. ProtonProtonProtonProton NMRNMRNMRNMR spectrumspectrumspectrumspectrum analysisanalysisanalysisanalysis ofofofof testtesttesttest samplesamplesamplesample
1. For 26 protons observed in the 1H NMR spectrum of DMSO-d6 solvent of this product,three
groups of peak at low field will disappear in heavy water,the other peak will become wider
apparently and part of them have shifted. The amount and type of hydrogen atom of the
test sample is consistent with that of the chemical structural formula of Cefoperazone sodium.
2. 9.72 and9.30 at low field is separately weakly coupled with5.51 and5.53 in COSY
spectrum,with the coupling constant separately being 6.8Hz and 8.0Hz,but they will disappear
in the heavy water spectrum.Obviously,the two above-mentioned peaks belong to NH3,which
shows that there exist NHCH structure in this compound.
3. Both7.20 and6.74 belong to d desintegration,and JHH equals to 8Hz.Both peaks correspond
to 2 protons,which produce strong coupling information in COSY spectrum and belong to para
substitution benzene proton contribution.
4. 1.08 at high field corresponds to 3 proton contribution,and belongs to triple
disintegration,which produces coupling information with 3.37 in COSY spectrum and
belongs to CH3 proton contribution.All these show that there exist CH2CH3 structure. 3.91 is
a single peak and its signal strength corresponds to 3 proton resonance,which falls within
lowest field and belongs to NCH3 proton contribution.
5. Two groups of peaks of 4.41 and4.21 constitute d disintegration with same coupling
constant,which produce strong coupling information in COSY spectrum.The two groups of
peaks constitute quadri peaks which show high inside and low outside,and is represented as
typical AB self-rotating system.
6. 1H NMR spectrum of the test sample is consistent with that of the reference standard.
VII.VII.VII.VII.13131313CCCC NMRNMRNMRNMR
Apparatus: Unity-400 nuclear magnetic resonance spectrometer
HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory
CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium
Solvent:Deuterated water(D2O), reference standard:DMSO=39.5
i.i.i.i. One-dimensionalOne-dimensionalOne-dimensionalOne-dimensional 13131313CCCC NMRNMRNMRNMR testtesttesttest
1. One-dimensional 13C NMR test
a.13C NNE NMR spectrum of reference standard
b. 13C DEPT NMR spectrum of reference standard
c. 13C NNE NMR spectrum of test sample
d. 13C DEPT NMR spectrum of test sample
2.13C NMR test data table of test sample
Serial no. ofpeak
Chemical shift Multiplicity Amount of C Correponding type of C
12345678910111213141516171819202122
171.28166.53163.25159.03155.78155.67153.04151.94129.81127.85126.68117.62115.0457.8457.0356.6042.3439.7035.4733.1425.7010.44
sssssssssdssddddtttqtq
1111111112112111211111
>C=O=CC=O>C=O>C=O>C=O>C=O=C